30.1 C
New York
Tuesday, June 25, 2024

Innovate Law Episode 1 | Annette Kleiser, CEO Dalan Animal Health

05 June 2024

Health Care Law Today

Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates

Antibody-drug conjugates are a promising class of cancer treatments with an accelerating number of U.S. Food and Drug Administration approvals and rapidly growing market size, as discussed in previous articles in this series.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles

error: Content is protected !!